Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Research Frontiers Incorporated is an electronic components business based in the US. Research Frontiers Incorporated shares (REFR) are listed on the NASDAQ and all prices are listed in US Dollars. Research Frontiers Incorporated employs 6 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$2.25|
|52-week range||$1.76 - $5.66|
|50-day moving average||$2.44|
|200-day moving average||$2.38|
|Wall St. target price||$3.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.08|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-18)||-3.85%|
|1 month (2021-09-24)||-16.97%|
|3 months (2021-07-26)||3.21%|
|6 months (2021-04-26)||-20.21%|
|1 year (2020-10-23)||-23.99%|
|2 years (2019-10-25)||-34.40%|
|3 years (2018-10-25)||65.44%|
|5 years (2016-10-25)||2.25|
|Gross profit TTM||$-1,949,085|
|Return on assets TTM||-23.95%|
|Return on equity TTM||-45.14%|
|Market capitalisation||$71.2 million|
TTM: trailing 12 months
There are currently 990,154 Research Frontiers Incorporated shares held short by investors – that's known as Research Frontiers Incorporated's "short interest". This figure is 12.5% down from 1.1 million last month.
There are a few different ways that this level of interest in shorting Research Frontiers Incorporated shares can be evaluated.
Research Frontiers Incorporated's "short interest ratio" (SIR) is the quantity of Research Frontiers Incorporated shares currently shorted divided by the average quantity of Research Frontiers Incorporated shares traded daily (recently around 274280.88642659). Research Frontiers Incorporated's SIR currently stands at 3.61. In other words for every 100,000 Research Frontiers Incorporated shares traded daily on the market, roughly 3610 shares are currently held short.
However Research Frontiers Incorporated's short interest can also be evaluated against the total number of Research Frontiers Incorporated shares, or, against the total number of tradable Research Frontiers Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Research Frontiers Incorporated's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Research Frontiers Incorporated shares in existence, roughly 30 shares are currently held short) or 0.0327% of the tradable shares (for every 100,000 tradable Research Frontiers Incorporated shares, roughly 33 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Research Frontiers Incorporated.
Find out more about how you can short Research Frontiers Incorporated stock.
We're not expecting Research Frontiers Incorporated to pay a dividend over the next 12 months.
Research Frontiers Incorporated's shares were split on a 5:4 basis on 15 February 1994. So if you had owned 4 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Research Frontiers Incorporated shares – just the quantity. However, indirectly, the new 20% lower share price could have impacted the market appetite for Research Frontiers Incorporated shares which in turn could have impacted Research Frontiers Incorporated's share price.
Over the last 12 months, Research Frontiers Incorporated's shares have ranged in value from as little as $1.76 up to $5.66. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Research Frontiers Incorporated's is 0.8. This would suggest that Research Frontiers Incorporated's shares are less volatile than average (for this exchange).
Research Frontiers Incorporated develops and markets technology and devices to control the flow of light worldwide. The company develops and licenses suspended particle device (SPD-Smart) light-control technology to companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, and electronics to power end-products incorporating the film, as well as lamination services for and the end-products, such as windows, skylights, and sunroofs. Its SPD-Smart light-control technology is used in various product applications, including windows, sunshades, skylights, and interior partitions for homes and buildings; automotive windows, sunroofs, sun-visors, sunshades, rear-view mirrors, instrument panels, and navigation systems; aircraft windows; museum display panels, and eyewear products; and flat panel displays for electronic products. The company serves architectural, automotive, marine, and aerospace and appliance applications. Research Frontiers Incorporated was incorporated in 1965 and is headquartered in Woodbury, New York. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.